Nautilus Biotechnology Reports Second Quarter 2024 Financial Results
Nautilus Biotechnology, Inc. (NAUT)
Company Research
Source: GlobeNewswire
SEATTLE, July 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second quarter ended June 30, 2024. “In Q2, we saw continued progress against core development goals for each of the components of our platform,” said Sujal Patel, CEO of Nautilus. “We believe we are pioneering a fundamentally new approach that holds the potential to overcome the limitations of traditional and peptide-based protein analysis methods and to unlock the value of the proteome – both in targeted proteoform analysis and broadscale discovery – something we continue to view as one of the most significant untapped opportunities in biological science.” Second Quarter 2024 Financial Results Operating expenses were $20.8 million for the second quarter of 2024, a $1.8 million or 9% increase from $19.0 million for the corresponding prior year period. The increase in oper
Show less
Read more
Impact Snapshot
Event Time:
NAUT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NAUT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NAUT alerts
High impacting Nautilus Biotechnology, Inc. news events
Weekly update
A roundup of the hottest topics
NAUT
News
- Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing OfficerGlobeNewswire
- Nautilus Biotechnology Insider Ups Holding During Year [Yahoo! Finance]Yahoo! Finance
- Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceGlobeNewswire
- Nautilus Biotechnology Reports Second Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024GlobeNewswire
NAUT
Earnings
- 7/30/24 - Beat
NAUT
Sec Filings
- 9/18/24 - Form 4
- 9/17/24 - Form 4
- 9/17/24 - Form 3
- NAUT's page on the SEC website